Centauri Therapeutics Limited is a privately held immunotherapy company with its primary headquarters located in London, United Kingdom.
Subscribe to see Centauri Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Centauri Therapeutics is a biotechnology company headquartered in United Kingdom, founded in 2014. Its most recent funding round, Series A, raised $32.9M in February 2026. Xcout tracks 11 named people at Centauri Therapeutics, including Jennifer Schneider (Chief Executive Officer , Director).
5 more named people on record for Centauri Therapeutics, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $32.9M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.